These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 21765074)

  • 1. Ocular manifestations of candidemia.
    Oude Lashof AM; Rothova A; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Schlamm HT; Oborska IT; Rex JH; Kullberg BJ
    Clin Infect Dis; 2011 Aug; 53(3):262-8. PubMed ID: 21765074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
    Rex JH; Bennett JE; Sugar AM; Pappas PG; van der Horst CM; Edwards JE; Washburn RG; Scheld WM; Karchmer AW; Dine AP
    N Engl J Med; 1994 Nov; 331(20):1325-30. PubMed ID: 7935701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year retrospective review of guideline-based management of fungal endophthalmitis.
    Narendran N; Balasubramaniam B; Johnson E; Dick A; Mayer E
    Acta Ophthalmol; 2008 Aug; 86(5):525-32. PubMed ID: 18752527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination antifungal therapy with voriconazole for persistent candidemia in very low birth weight neonates.
    Turan O; Ergenekon E; Hirfanoğlu IM; Onal EE; Baş VN; Türkyilmaz C; Koç E; Atalay Y
    Turk J Pediatr; 2011; 53(1):19-26. PubMed ID: 21534335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of treatment for candidemia and risk for late-onset ocular candidiasis.
    Blennow O; Tallstedt L; Hedquist B; Gårdlund B
    Infection; 2013 Feb; 41(1):129-34. PubMed ID: 23212461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.
    Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR
    Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral Candida endophthalmitis accompanying Candida lusitaniae bloodstream infection: A case report.
    Yamamoto S; Ikeda M; Fujimoto F; Okamoto K; Wakabayashi Y; Sato T; Tatsuno K; Kaburaki T; Yoshida S; Okugawa S; Koike K; Moriya K
    J Infect Chemother; 2018 Feb; 24(2):147-149. PubMed ID: 29102349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
    Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
    Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
    Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
    Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida infections in non-neutropenic children after the neonatal period.
    Hacimustafaoglu M; Celebi S
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and risk factors of ocular candidiasis.
    Nagao M; Saito T; Doi S; Hotta G; Yamamoto M; Matsumura Y; Matsushima A; Ito Y; Takakura S; Ichiyama S
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):149-52. PubMed ID: 22503164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology.
    Rodríguez-Adrián LJ; King RT; Tamayo-Derat LG; Miller JW; Garcia CA; Rex JH
    Medicine (Baltimore); 2003 May; 82(3):187-202. PubMed ID: 12792305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.
    Riddell J; Comer GM; Kauffman CA
    Clin Infect Dis; 2011 Mar; 52(5):648-53. PubMed ID: 21239843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.